DrugPatentWatch Database Preview
Baxter Hlthcare Company Profile
What is the competitive landscape for BAXTER HLTHCARE, and when can generic versions of BAXTER HLTHCARE drugs launch?
BAXTER HLTHCARE has one hundred and ninety-four approved drugs.
There are five US patents protecting BAXTER HLTHCARE drugs. There are two tentative approvals on BAXTER HLTHCARE drugs.
Summary for Baxter Hlthcare
| US Patents: | 5 |
| Tradenames: | 304 |
| Ingredients: | 111 |
| NDAs: | 194 |
Drugs and US Patents for Baxter Hlthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 018581-001 | Jul 28, 1982 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Baxter Hlthcare | PROCHLORPERAZINE | prochlorperazine edisylate | INJECTABLE;INJECTION | 087759-001 | Oct 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Baxter Hlthcare | TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER | amino acids; dextrose; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride | INJECTABLE;INJECTION | 020147-007 | Oct 23, 1995 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Baxter Hlthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | IFEX/MESNEX KIT | ifosfamide; mesna | INJECTABLE;INJECTION | 019763-004 | Oct 10, 1992 | 4,220,660 | ➤ Sign Up |
| Baxter Hlthcare | IFEX/MESNEX KIT | ifosfamide; mesna | INJECTABLE;INJECTION | 019763-004 | Oct 10, 1992 | 5,696,172 | ➤ Sign Up |
| Baxter Hlthcare | FORANE | isoflurane | LIQUID;INHALATION | 017624-001 | Approved Prior to Jan 1, 1982 | 3,535,425 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for BAXTER HLTHCARE drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Inhalation | 99.90% | ➤ Subscribe | 2008-09-11 |
| ➤ Subscribe | Injection | 10 mg/mL, 250 mL infusion bags and 20 mg/mL, 100 mL infusion bags | ➤ Subscribe | 2014-01-31 |
International Patents for Baxter Hlthcare Drugs
Supplementary Protection Certificates for Baxter Hlthcare Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 90026-1 | Sweden | ➤ Sign Up | PRODUCT NAME: 4-AMINOPYRIDIN ELLER ETT SALT ELLER SOLVAT DAERAV; REG. NO/DATE: EU/1/11/699/001 20110720 |
| C0021 | Belgium | ➤ Sign Up | PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209 |
| 12/008 | Ireland | ➤ Sign Up | PRODUCT NAME: AZILSARTAN MEDOXOMIL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING THE POTASSIUM SALT; REGISTRATION NO/DATE: EU/1/11/734/001-011 EU/1/11/735/001-011 20111209 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
